Anzeige
Mehr »
Login
Montag, 29.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Basin Uranium: Es geht los! Der Uran-Superzyklus ist gestartet!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
10 Leser
Artikel bewerten:
(0)

delSECUR CORPORATION Announces Approval of the Majority of Shareholders in Favour of the Agreement to Purchase the Intellectual Property Assets of the Corporation

SOUTH BURLINGTON, Vt., Aug. 13 /PRNewswire-FirstCall/ -- delSECUR CORPORATION, a Nevada corporation, (Pink Sheets: DLSC) announced today that its Board of Directors has accepted the majority Consent vote of over 60% of its shareholders in favour of the agreement to purchase the Intellectual Property Assets of delSECUR CORPORATION which was announced on August 4th. The consideration for such purchase is in the form of a 49% interest in the shares of common stock of Q Tech Systems, Inc., an Ontario, Canada, corporation.

The primary asset acquired by Q Tech was the del-ID technology and its patents, a device and system of authenticating individuals through biometric means invented by Pierre de Lanauze, the former President & CEO of delSECUR CORPORATION. Q Tech, which also develops and markets technologies to enhance security and identification processes, plans to incorporate the del-ID technology with its proprietary technology. Q Tech will be immediately focusing on the invention of Pierre de Lanauze's analog technology. "We at Q Tech are excited about the prospects of the del-Id technology. Along with our technology and the del-Id patent designs you can bet we will be quickly at work with our technicians to produce a 'functional prototype,'" said Q Tech's President & CEO, John Johnston.

delSECUR, a public company (Pink Sheets: DLSC) with its head office in S. Burlington, VT., is a technology development company of a unique authentication process based on abstract images of biological data collected from the fingers of living persons.

This Press Release may contain forward-looking statements. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," and other similar statements. Statements that are not historical facts, including statements relating to anticipated future earnings, margins, and other operating results, future growth, construction plans and anticipated capacities, production schedules and entry into expanded markets are forward-looking statements. Such forward-looking statements, based upon the current beliefs and expectations of our management, are subject to risks and uncertainties, which could cause actual results to differ materially from the forward-looking statements and are subject to the risks normally associated with the completion of a corporate transaction. The information set forth herein should be read in light of such risks. We assume no obligation to update the information contained in this press release, except as required under applicable law.

delSECUR CORPORATION

CONTACT: Randall McCormick of delSECUR CORPORATION, +1-514-651-6610

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2009 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.